Ozempic and Eating Disorders: How a GLP-1 Helps and When It Hurts

We're not here to tell you whether you should be on Ozempic and any GLP-1 medication.

That conversation belongs between you and your doctor. And honestly? We know it's never that simple. The pressure to look a certain way is real. The medical system has complicated relationships with bodies that don't fit a narrow mold. And for a lot of people, starting a GLP-1 medication wasn't a casual decision. It came after years of navigating health concerns, provider recommendations, and a culture that never lets you forget what your body looks like.

We see all of that.

This post is for anyone who is currently taking a GLP-1 receptor agonist like semaglutide (sold as Ozempic or Wegovy), or who is in conversation with a provider about whether one might be appropriate. Either way, you deserve an honest, clinically grounded picture of what these medications actually do. The benefits, the nuance, and the risks that don't always make it into the conversation.

How GLP-1s Help People

GLP-1 receptor agonists are legitimate, effective medications. They were developed to treat type 2 diabetes and have since shown meaningful benefits for cardiovascular health and other metabolic conditions.

For many people, one of the most significant effects is the quieting of what many patients describe as "food noise": the constant, looping mental chatter about food, cravings, and what to eat next. For someone who has spent years exhausted by that internal static, that relief is real, and people often feel like they can finally breathe again.

For people with binge eating disorder specifically, emerging research suggests GLP-1 receptor agonists may do something more targeted, helping modulate the brain's reward circuits, the same pathways involved in compulsive eating. A 2025 systematic review and meta-analysis found improvements in binge eating scores in patients taking GLP-1 receptor agonists, though the finding was heterogeneous and the total sample across all five included studies was 182 people (Radkhah et al., 2025). The research is still early and the studies are small, but the signal is there.

For many people with a legitimate medical indication, these medications can meaningfully improve quality of life.

And they may also be affecting your relationship with food and hunger in ways worth understanding.

The Complicated Relationship Between Ozempic and Eating Disorders

Semaglutide and other GLP-1 receptor agonists work by mimicking a hormone your gut naturally releases after you eat. They slow digestion, reduce hunger signals in the brain, and dampen the reward response to food.

For some people, that feels like relief. For others, it opens a door that is harder to manage.

Here is what we see clinically:

If restriction has ever been part of your story, the appetite suppression can feel familiar. Comfortable, even, in a way that isn't entirely healthy. There is a difference between not eating because you're genuinely not hungry and not eating because restriction feels safe. When the outcome looks the same from the outside, it can be hard to tell where one ends and the other begins.

If binge eating has been your pattern, the quiet can feel like a rescue. Sometimes it is. But it's worth asking whether the emotional patterns underneath the bingeing are being worked through, or whether the medication is just creating distance from them. Distance isn't the same as healing.

If you're in eating disorder recovery, the physical changes and the relentless cultural conversation about these drugs can be destabilizing, even when the prescription is medically sound. Recovery isn't just about behavior. It's about the meaning you've built around food and your body. A medication doesn't touch that part.

If you have atypical anorexia, meaning you restrict significantly and live in a larger body, there is a real chance this was missed before you were prescribed a GLP-1. Atypical anorexia is more common than most providers realize, and it's dramatically underdiagnosed in people who don't appear to fit the stereotypical mold of anorexia. Research suggests that only 6% of eating disorder diagnoses occur in people who are medically underweight, and limited eating disorder training in primary care and endocrinology means that patients with atypical anorexia and non-purging bulimia are more likely to go undiagnosed or be misdiagnosed with binge eating disorder (NEDA, 2024). A medication that makes it easier not to eat can compound something that was already dangerous and invisible.

We Understand Why You’re Drawn to Ozempic and GLP-1 Medications

Here is what we don't do: tell people to simply stop caring about their weight, or act like opting out of diet culture is easy when you live in a body that gets judged every day.

We offer eating disorder therapy in Houston, Texas, from a Health at Every Size framework. That means we believe weight is not an accurate indicator of health. That doesn't mean we dismiss the very real concerns people carry about their bodies. We get it. We meet you where you actually are, not where we think you should be.

If you're on a GLP-1 and you're also carrying a complicated history with food, we're not going to ask you to choose between medical care and recovery. We're going to help you hold both and make the decision that is truly best for you. To make that decision, you deserve to be well-informed and to have support from a team that understands eating disorders and disordered eating.

Things Worth Staying Honest With Yourself About

You don't need a diagnosis for something to be worth noticing. A few questions to ask yourself:

• Are you using the medication's appetite suppression as permission to eat as little as possible?
• Do you feel anxious or guilty on days when you eat more than the medication makes you want to?
• Has the medication made you more focused on changing your body?
• Are you avoiding eating even when you're not physically full?
• Has anyone who knows you well expressed concern?

These questions are an invitation to get curious about yourself.

Thoughtful Support around Ozempic and Eating Disorders

The research on GLP-1 medications and eating disorders is genuinely young. Clinicians are still learning. Which means the quality of your support system matters more, not less.

Below are some key players in a comprehensive eating disorder therapy program. As eating disorder therapists in Houston, we already partner with many of these providers and are happy to provide referrals and collaborate.

An Eating Disorder Therapist

Your relationship with food is changing. Having someone in your corner while that happens makes sense.

A HAES-Informed Registered Dietitian

Reduced hunger doesn't mean reduced need. Someone who understands both nutrition and eating disorder recovery can help you make sure your body is actually getting what it needs.

A Prescribing Physician Who Understands Your History

That includes any past relationship with restriction, bingeing, purging, or disordered eating. You deserve more frequent check-ins if things feel complicated, and a provider who takes your mental health as seriously as your physical health.

A Plan for Transitions

Stopping a GLP-1 can shift appetite and eating patterns significantly. Having support already in place before that happens is a lot better than trying to find quality support in the middle of it.

Help with Ozempic and Eating Disorders in Houston

Our specialized eating disorder therapists in Houston, Texas, understand Ozempic, GLP-1 medications, and eating disorders. We know recovery isn't linear, that the pressure to look a certain way doesn't just stop, and that people come to us at all different points. In crisis, in recovery, or somewhere in between. Wherever you are is a valid place to start.

If you're on a GLP-1 or considering one, and something about the experience is bringing up old patterns, new anxieties, or questions you can't quite articulate yet, that's enough of a reason to reach out.

Contact us to schedule a free 15-minute consultation and learn more about specialized eating disorder treatment in-person in Houston and virtually for all of Texas.

References

Radkhah, H., Rahimipour Anaraki, S., Parhizkar Roudsari, P., et al. (2025). The impact of glucagon-like peptide-1 (GLP-1) agonists in the treatment of eating disorders: a systematic review and meta-analysis. Eating and Weight Disorders, 30(1), 10. https://doi.org/10.1007/s40519-025-01720-9



National Eating Disorders Association. (2024). GLP-1 medications and eating disorders. https://www.nationaleatingdisorders.org/glp-and-eating-disorders/

Frequently Asked Questions About Ozempic and Eating Disorders